HUMANA INC vs Oscar Health, Inc., two Managed Care stocks. A side-by-side on valuation, growth, margins, returns, and what each price is betting.
Where HUM and OSCR diverge most: on fcf yield, HUM reads 2.6% and OSCR reads 40.1%; on return on equity, HUM reads 6.1% and OSCR reads 26.8%. The rest of the comparable metrics sit closer together. The bull and bear cases for each are in their full reports below.
| Metric | HUM | OSCR |
|---|---|---|
| Price | $409.86 | $32.75 |
| Market cap | $49.5B | $10.9B |
| Sector | Managed Care | Managed Care |
| Stage | Growth | Growth |
| P/E | — | 22.6 |
| P/B | 2.65 | 5.31 |
| P/S | 0.36 | 0.71 |
| EV/EBITDA | 18.3 | 11.4 |
| Revenue growth | +13.9% | +40.9% |
| Operating margin | 4.4% | 8.0% |
| Net margin | 0.8% | 3.6% |
| Return on equity | 6.1% | 26.8% |
| Return on assets | 2.0% | 4.9% |
| Return on invested capital | 5.9% | 23.9% |
| FCF yield | 2.6% | 40.1% |
| Dividend yield | 0.9% | — |
| Debt / equity | 0.75 | 0.21 |
| Current ratio | 1.77 | 1.08 |
| Altman Z (solvency) | 4.52 | 1.99 |
| Piotroski F (quality) | 8 / 9 | 6 / 9 |
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
The stronger value is highlighted per metric where one is strictly better on that single number; it is not an overall verdict on either company. For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.